Variant report
Variant | nsv549195 |
---|---|
Chromosome Location | chr1:216198015-216215518 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs75234728 | chr1:216204813-216204814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs141619143 | chr1:216204830-216204831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs542933548 | chr1:216204886-216204887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs542171485 | chr1:216204898-216204899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs559333998 | chr1:216204906-216204907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs572974046 | chr1:216204918-216204919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs12120923 | chr1:216204949-216204950 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs181853905 | chr1:216204967-216204968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs530865378 | chr1:216205053-216205054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs550569059 | chr1:216205091-216205092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs376694249 | chr1:216205097-216205098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs12121718 | chr1:216205110-216205111 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs558997492 | chr1:216205183-216205184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs546867942 | chr1:216205184-216205185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs566987505 | chr1:216205221-216205222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs539236201 | chr1:216205245-216205246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs147039794 | chr1:216205272-216205273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs12141297 | chr1:216205281-216205282 | Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
19 | rs186105492 | chr1:216205326-216205327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs368846864 | chr1:216205386-216205387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs536270621 | chr1:216206037-216206038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs552667855 | chr1:216206048-216206049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs566766065 | chr1:216206066-216206067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs6676313 | chr1:216206083-216206084 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs558761426 | chr1:216206117-216206118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs6687538 | chr1:216206138-216206139 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs553835609 | chr1:216206151-216206152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs544333915 | chr1:216206162-216206163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs554658489 | chr1:216206227-216206228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs574562898 | chr1:216206261-216206262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs143208835 | chr1:216206290-216206291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs560248499 | chr1:216206291-216206292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs373517226 | chr1:216206299-216206300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs546177179 | chr1:216206368-216206369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs182330044 | chr1:216206386-216206387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs148271190 | chr1:216206474-216206475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs548768106 | chr1:216206476-216206477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs567392115 | chr1:216206485-216206486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs74143911 | chr1:216206499-216206500 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs73094506 | chr1:216206563-216206564 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs187692118 | chr1:216206628-216206629 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs538948690 | chr1:216206661-216206662 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs542257038 | chr1:216206713-216206714 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs192581563 | chr1:216206733-216206734 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs555727531 | chr1:216206736-216206737 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs11120725 | chr1:216206768-216206769 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs572455702 | chr1:216206783-216206784 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs116360680 | chr1:216206881-216206882 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs74903767 | chr1:216206909-216206910 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs534026674 | chr1:216206970-216206971 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
Multiple myeloma | 16461302 | CNVD |
van der Woude syndrome | 22470819 | CNVD |
van der Woude syndrome | 20818247 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21720365 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Holoprosencephaly | 19184110 | CNVD |
Breast cancer | 21069454 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Mental retardation | 19951919 | CNVD |
Non-syndromic sensorineural hearing loss | 17873649 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Lung cancer | 16740712 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Developmental delay | 21147756 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:216204800-216205400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr1:216206000-216206600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr1:216206000-216207200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
4 | chr1:216206600-216211800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr1:216211800-216212200 | Strong transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr1:216212200-216216800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |